Suvorexant for Opioid/Stimulant Co-use

NCT05546515 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder
Stimulant Use Disorder

Interventions

DRUG: Suvorexant (dual orexin receptor antagonist)
DRUG: Placebo

Sponsor

Johns Hopkins University